Atricure Inc
Research Atricure Inc (ATRC) on Bullrun: market cap USD 2.48B, P/E 225.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerATRC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 2.48B
- P/E225.0
- Financial periodQ2 2026
- RevenueUSD 153.60M
- Net incomeUSD 8.96M
- Free cash flowUSD 18.43M
- Gross margin77.2%
Valuation Snapshot
latest market cap is USD 2.48B; P/E is 225.0.
Peer valuation comparison
Latest P/E is 224.95x versus a Healthcare sector median of 24.46x (819.7% above).
Latest P/E is 224.95x versus a United States median of 24.87x (804.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 534.53M | -USD 11.45M | USD 48.28M | 75.0% | -0.24 | USD 167.43M | USD 61.87M | USD 491.94M |
| FY2024 | USD 465.31M | -USD 44.70M | USD 745.00K | 74.7% | -0.95 | USD 122.72M | USD 61.87M | USD 460.97M |
| FY2023 | USD 399.25M | -USD 30.44M | -USD 7.51M | 75.2% | -0.66 | USD 84.31M | USD 60.59M | USD 466.17M |
| FY2022 | USD 330.38M | -USD 46.47M | -USD 39.02M | 74.4% | -1.02 | USD 58.10M | USD 56.83M | USD 456.75M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.48B | 225.0 | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.97B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.49B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.69B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.06B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.20B | 65.6 | n/a | n/a |
About Atricure Inc
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Atricure Inc's market cap?
Atricure Inc's market capitalization is USD 2.48B.
What is Atricure Inc's P/E ratio?
Atricure Inc's price-to-earnings (P/E) ratio is 225.0.
What does Atricure Inc do?
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.